Page last updated: 2024-12-08

stephenanthrine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

stephenanthrine: from the root of Stephania tetranda S. Moore & Dennettia tripetala; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

stephanthrine : An organic heterotetracyclic compound that is 2-(2H-phenanthro[3,4-d][1,3]dioxole in which the hydrogen at position 5 has been replaced by a 2-(dimethylamino)ethyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Dennettiagenus[no description available]AnnonaceaeThe custard-apple plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. Some members provide large pulpy fruits and commercial timber. Leaves and wood are often fragrant. Leaves are simple, with smooth margins, and alternately arranged in two rows along the stems.[MeSH]
StephaniagenusA plant genus of the family MENISPERMACEAE. Members contain cycleanine.[MeSH]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]
StephaniagenusA plant genus of the family MENISPERMACEAE. Members contain cycleanine.[MeSH]MenispermaceaeA plant family of the order Ranunculales, subclass Magnoliidae, class Magnoliopsida. Members are mostly vines and shrubs and they contain isoquinoline alkaloids, some of which have been used as arrow poisons.[MeSH]

Cross-References

ID SourceID
PubMed CID161379
CHEMBL ID492418
CHEBI ID132896
SCHEMBL ID10726686
MeSH IDM0141582

Synonyms (28)

Synonym
HMS1481N09
OPREA1_353681
stephanthrine
OPREA1_105893
CHEMDIV3_003111
dimethyl-(2-phenanthro[3,4-d][1,3]dioxol-5-yl-ethyl)-amine
MLS001207641 ,
smr000517938
NCGC00160247-01
n,n-dimethyl-2-(2h-phenanthro[3,4-d][1,3]dioxol-5-yl)ethan-1-amine
CHEBI:132896
22108-99-2
BRD-K06143692-003-01-4
CHEMBL492418
mfcd02184572
AKOS001648896
phenanthro(3,4-d)-1,3-dioxole-5-ethanamine, n,n-dimethyl-
stephenanthrine
SCHEMBL10726686
n,n-dimethyl-2-naphtho[2,1-g][1,3]benzodioxol-5-ylethanamine;hydrochloride
bdbm69679
us9211296, table 7, compd: 10
n,n-dimethyl-2-naphtho[2,1-g][1,3]benzodioxol-5-yl-ethanamine;hydrochloride
cid_24746882
dimethyl(2-naphtho[2,1-g][1,3]benzodioxol-5-ylethyl)amine;hydrochloride
n,n-dimethyl-2-(5-naphtho[2,1-g][1,3]benzodioxolyl)ethanamine;hydrochloride
ncgc00160247-01!stephenanthrine
DTXSID40944752
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
cyclic acetalAn acetal in the molecule of which the acetal carbon and one or both oxygen atoms thereon are members of a ring.
organic heterotetracyclic compound
tertiary amino compoundA compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency22.38720.003245.467312,589.2998AID2517
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency7.06270.140911.194039.8107AID2451
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency28.18380.177814.390939.8107AID2147
Microtubule-associated protein tauHomo sapiens (human)Potency17.78280.180013.557439.8107AID1460
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency39.81070.354828.065989.1251AID504847
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency1.25890.00798.23321,122.0200AID2551
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DRattus norvegicus (Norway rat)Ki5.24350.00010.610010.0000AID764954
D(2) dopamine receptorRattus norvegicus (Norway rat)Ki0.06540.00000.437510.0000AID764955
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (27)

Assay IDTitleYearJournalArticle
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID496605Inhibition of mitochondrion topoisomerase 1A in Trypanosoma brucei brucei MiTat 1.2 strain 427 bloodstream assessed as protection of linerarizd minicircle from lambda exonuclase at 63 uM2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
AID390739Antiviral activity against Vaccinia virus WR in BSC1 cells assessed as protection from virus-induced lysis of cell monolayer up to 200 uM after 20 hrs2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.
AID496613Inhibition of topoisomerase in Trypanosoma brucei brucei MiTat 1.2 strain 427 bloodstream assessed as enzyme-DNA cleavable complex at 50 uM (RvB = 2.2 +/- 0.05%)2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
AID764954Displacement of [3H]-SCH23390 from D1 receptor of Wistar rat striatal membranes after 1 hr by liquid scintillation counting2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
3,4-Dihydroxy- and 3,4-methylenedioxy- phenanthrene-type alkaloids with high selectivity for D2 dopamine receptor.
AID390738Antiviral activity against Vaccinia virus WR in BSC1 cells assessed as reduction in plaque formation up to 200 uM after 20 hrs2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.
AID496612Binding affinity to plasmid DNA assessed as DNA unwinding in presence of vaccinia virus topoisomerase 1B by electrophoresis2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
AID764955Displacement of [3H]-raclopride from D2 receptor of Wistar rat striatal membranes after 1 hr by liquid scintillation counting2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
3,4-Dihydroxy- and 3,4-methylenedioxy- phenanthrene-type alkaloids with high selectivity for D2 dopamine receptor.
AID496609Antitrypanosomal activity against Trypanosoma brucei brucei MiTat 1.2 strain 427 bloodstream assessed as decrease in topoisomerase 1Amt level at 0-120 uM2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
AID764953Selectivity ratio of Ki for D1 receptor of Wistar rat striatal membranes to Ki for D2 receptor of Wistar rat striatal membranes2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
3,4-Dihydroxy- and 3,4-methylenedioxy- phenanthrene-type alkaloids with high selectivity for D2 dopamine receptor.
AID496610Antitrypanosomal activity against Trypanosoma brucei brucei MiTat 1.2 strain 427 bloodstream assessed as decrease in topoisomerase 2mt level at 0-100 uM2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
AID496611Antitrypanosomal activity against Trypanosoma brucei brucei MiTat 1.2 strain 427 bloodstream assessed as decrease in topoisomerase 2mt level at 0-120 uM2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
AID496614Inhibition of topoisomerase in Trypanosoma brucei brucei MiTat 1.2 strain 427 bloodstream assessed as enzyme -DNA cleavable complex at 50 uM relative to DMSO2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
AID496607Inhibition of mitochondrion topoisomerase 1A in Trypanosoma brucei brucei MiTat 1.2 strain 427 bloodstream assessed as protection of linerarizd minicircle from exonuclase 3 at 63 uM2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
AID496603Inhibition of mitochondrion topoisomerase 1A in Trypanosoma brucei brucei MiTat 1.2 strain 427 bloodstream assessed as increase in protein-sensitive linear DNA forms at 60-100 uM2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
AID390740Cytotoxicity against african green monkey BSC1 cells up to 200 uM after 20 to 120 hrs WST-1 based assay2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.
AID496602Inhibition of mitochondrion topoisomerase 1A in Trypanosoma brucei brucei MiTat 1.2 strain 427 bloodstream assessed as increase in protein-sensitive linear DNA forms at 0-40 uM2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
AID496608Antitrypanosomal activity against Trypanosoma brucei brucei MiTat 1.2 strain 427 bloodstream assessed as decrease in topoisomerase 1Amt level at 0-100 uM2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
AID496601Antitrypanosomal activity against Trypanosoma brucei brucei MiTat 1.2 strain 427 bloodstream by acid phosphatase method2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
AID496604Inhibition of mitochondrion topoisomerase 1A in Trypanosoma brucei brucei MiTat 1.2 strain 427 bloodstream assessed as protection of linerarizd minicircle from lambda exonuclase at 25.5 uM2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
AID390731Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.
AID496606Inhibition of mitochondrion topoisomerase 1A in Trypanosoma brucei brucei MiTat 1.2 strain 427 bloodstream assessed as protection of linerarizd minicircle from exonuclase 3 at 25.5 uM2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's4 (44.44)24.3611
2020's2 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.08 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]